Select a year:

4Moving Biotech at OARSI 2023

Our subsidiary 4Moving Biotech, was presented at OARSI- World Congress on Osteoarthritis. It was an excellent opportunity to share our subsidiary’s latest progress and development. Our subsidiary Co-founder/CMO Pr. Francis Berenbaum showcased two posters during the OARSI congress. First poster at OA clinical trial symposium on March 16, 2023 Poster title: GLP1 analogues as a&hellip

Read More

4Moving Biotech is attending at Gordon Research Conference

We are delighted to announce that Pr. Francis Berenbaum, Co-founder and CEO/CMO of our subsidiary 4Moving Biotech, is attending from March 19th-24th,2023, at Gordon Research Conference in Luca, Bragia, Italia as an invitedspeaker. His poster title is Glucagon-like Peptide-1 Analogues: Metabolic Roles and Beyond

Read More

4P-Pharma will attend the 17th annual BIO-Europe Spring

4P-Pharma will attend the 17th annual BIO-Europe Spring on March 20–22, 2023, in Basel, Switzerland. Our Chief Development Officer, Frédéric Marin and our Business Development & Licensing-in Manager, Roselina Lam will be participating in this European biotechs and Pharma’s large spring event. Feel free to contact us, to make an appointment, to discuss partnering or&hellip

Read More

4P-Pharma is attending JP Morgan Week 2023

We are pleased to attend JPM Week 2023 from January 9th to 11th in California, United States. Our CEO Revital Rattenbach is looking forward to seeing you in person at this significant networking event for our healthcare ecosystem. Meet her at the French Healthcare Corner during JPM week 2023.

Read More

Discover 4P-Pharma’s clinical vision

4P-Pharma is thrilled to share the last video of company portrait galleries realized in collaboration with the magazine Entreprendre to highlight our innovative company activities and story. This video focuses on our clinical vision, aiming to rapidly deliver effective, regenerated, first-in-class therapies for untreated serious diseases with high unmet medical needs. 4P-Pharma has developed a&hellip

Read More